eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2014
vol. 31
 
Share:
Share:
abstract:

Case report
Sweet’s syndrome with idiopathic thrombocythemia

Sebastian Kaszewski
,
Rafał Czajkowski
,
Franciszka Protas-Drozd
,
Waldemar Placek
,
Sebastian Jakubowski

Postep Derm Alergol 2014; XXXI, 1: 47–52
Online publish date: 2014/02/25
View full text Get citation
 
Diagnosis of paraneoplastic skin syndromes associating neoplastic processes is assumed as the crucial aspect of dermatological practice. Knowledge of clinical findings of dermatoses suggesting coincidence of malignant proliferative processes facilitates diagnostic and therapeutic procedures. We would like to present a case of Sweet’s syndrome, qualified for comparative paraneoplastic skin syndromes. Sweet’s syndrome, acute, febrile neutrophilic dermatosis, was first described by Robert Douglas Sweet in 1964 as a disorder characterized by fever, skin lesions of erythematous-infiltrative character, leukocytosis with neutrophilia and dense infiltrations of dermis by mature neutrophils. Sweet’s syndrome aetiology is not fully understood, although cytokine abnormalities suggest that Th1 lymphocytes play an important role in pathogenesis of the dermatosis. Factors inducing Sweet’s syndrome include: haematopoietic hyperplasia; neoplasms: genitourinary, breast, gastrointestinal; infections of the respiratory and alimentary system; inflammatory bowel diseases; drugs; pregnancy and vaccinations. Systemic corticosteroids are the “gold standard” of Sweet’s syndrome treatment; potassium iodide or colchicine may also be used. Indomethacin, clofazimine, cyclosporine A and sulfones are the second-line drugs.
keywords:

Sweet’s syndrome, acute febrile, neutrophilic dermatosis, paraneoplasia, thrombocythemia

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.